Gene Editing for Rare Diseases: The "N-of-1" Revolution in 2025
In 2025, the medical community has finally addressed a long-standing tragedy: the thousands of rare diseases that were too niche for pharmaceutical companies to notice. Thanks to gene editing, we have entered the era of "N-of-1" medicine, where a therapy can be designed and manufactured for a single individual with a unique genetic mutation. By using a "modular" CRISPR platform, scientists can...
0 Commentarios 0 Acciones 3 Views 0 Vista previa
Cryell https://cryell.com